Practical Application of DaTQUANT with Optimal Threshold for Diagnostic Accuracy of Dopamine Transporter SPECT
Open Access
- 18 December 2021
- journal article
- research article
- Published by MDPI AG in Tomography
- Vol. 7 (4) , 980-989
Abstract
Evaluation of Parkinsonian Syndromes (PS) with Ioflupane iodine-123 dopamine transporter single photon emission computed tomography (DaT-SPECT), in conjunction with history and clinical examination, aids in diagnosis. FDA-approved, semi-quantitative software, DaTQUANTTM (GE Healthcare, Chicago, IL, USA) is available to assist in interpretation. This study aims to evaluate the optimal variables and thresholds of DaTQUANT to yield the optimal diagnostic accuracy. It is a retrospective review with three different patient populations. DaT-SPECT images from all three study groups were evaluated using DaTQUANTTM software, and both single and multi-variable logistic regression were used to model PS status. The optimal models were chosen via accuracy, sensitivity, and specificity, then evaluated on the other study groups. Among single variable models, the posterior putamen yielded the highest accuracy (84% to 95%), while balancing sensitivity and specificity. Multi-variable models did not substantially improve the accuracy. When the optimal single variable models for each group were used to evaluate the remaining two groups, comparable results were achieved. In typical utilization of DaT-SPECT for differentiation between nigrostriatal degenerative disease (NSDD) and non-NSDD, the posterior putamen was the single variable that yielded the highest accuracy across three different patient populations. The posterior putamen’s recommended thresholds for DaTQUANT are SBR ≤ 1.0, z-score of ≤−1.8 and percent deviation ≤ −0.34.Keywords
Funding Information
- General Electric (4252270)
This publication has 27 references indexed in Scilit:
- Receiver-Operating-Characteristic Analysis of an Automated Program for Analyzing Striatal Uptake of 123I-Ioflupane SPECT Images: Calibration Using Visual ReadsJournal of Nuclear Medicine Technology, 2013
- Neuropathological correlates of dopaminergic imaging in Alzheimer's disease and Lewy body dementiasBrain, 2012
- Impact of DaTscan SPECT imaging on clinical management, diagnosis, confidence of diagnosis, quality of life, health resource use and safety in patients with clinically uncertain parkinsonian syndromes: a prospective 1-year follow-up of an open-label controlled studyJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Dopamine transporter imaging in autopsy‐confirmed Parkinson's disease and multiple system atrophyMovement Disorders, 2011
- Parkinson's disease is overdiagnosed clinically at baseline in diagnostically uncertain cases: A 3‐year European multicenter study with repeat [123I]FP‐CIT SPECTMovement Disorders, 2009
- Optimized, Automated Striatal Uptake Analysis Applied to SPECT Brain Scans of Parkinson's Disease PatientsJournal of Nuclear Medicine, 2007
- Comparative analysis of visual and semi-quantitative assessment of striatal [123I]FP-CIT-SPET binding in Parkinson's diseaseNeurological Sciences, 2006
- Striatal dopamine transporter in dementia with Lewy bodies and Parkinson diseaseNeurology, 2004
- Striatal dopamine transporter binding in early to moderately advanced Parkinsonʼs disease: monitoring of disease progression over 2 yearsNuclear Medicine Communications, 2001
- Approximate is Better than “Exact” for Interval Estimation of Binomial ProportionsThe American Statistician, 1998